搜尋優化
Rewards
Svenska
|
English
搜尋
Copilot
圖片
影片
地圖
新聞
購物
更多
航班
旅遊
旅館
我的 Bing
筆記本
Huvudrubriker
Sverige
Världen
Nöje
Affärer
Sport
Vet./tek.
任何時間
過去 1 小時
過去 24 小時
過去 7 天
過去 30 天
最近的新聞
最符合項目
STAT
53 分鐘
Intellia’s CRISPR-based treatment dramatically reduced patients’ swelling attacks in small trial
The first patients to receive Intellia's CRISPR-based therapy for hereditary angioedema saw their swelling attacks virtually ...
STAT
1 小時
ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth
AstraZeneca is having another big ASCO, but the art of comfort care for cancer patients also got a plenary session.
STAT
3 小時
Palliative care for cancer patients is found to be as effective given virtually as in person
When palliative care is delivered via telehealth, there are a number of advantages. They can be at home, in their pajamas, ...
STAT
9 小時
AstraZeneca’s Tagrisso greatly slows cancer for some people with stage 3 lung cancer
AstraZeneca reports at ASCO that its drug Tagrisso slowed down lung cancer progression for a median of several years in stage ...
STAT
10 小時
ASCO 2024: Data put a new shine on GSK blood cancer drug that was pulled from market
The resurrection of a GSK blood cancer drug — which the company withdrew from the U.S. market not even two years ago — is ...
STAT
10 小時
With new results at ASCO, Enhertu once again rewrites rules of breast cancer treatment
At ASCO, Astra Zeneca reported that its drug Enhertu stalled the growth of tumors by more than a year in women with the most ...
STAT
1 天
ASCO Daily Recap: Safety data for Novartis myelofibrosis candidate, survival data for Pfizer drug
Recap: Today's top stories from ASCO 2024 include updates on safety data about a myelofibrosis candidate, and record ...
STAT
1 天
ASCO 2024: FDA oncology head wants clinical trials to range beyond China alone
At an ASCO 2024 event, Richard Pazdur, the FDA's top oncologist, said the agency wants to see companies conducting studies ...
STAT
1 天
At ASCO, pharma leaders explain how ‘smart bomb’ drugs became useful against more cancers
At a STAT event, oncology leaders spoke of advances that are turning old ideas like antibody-drug conjugates into broadly ...
STAT
1 天
With expectations rising, Corbus reveals new data on its ADC bladder cancer treatment
Corbus, reporting on early trials of its antibody-drug conjugate, says it "seems to be clinically effective in bladder cancer ...
STAT
1 天
How can hospitals boost cancer screening rates? Researchers report that an AI helped
CHICAGO — People can be mightily reluctant to get a colonoscopy for reasons like cost, language barriers, or fear of what the ...
STAT
1 天
Readers respond to essays on young caregivers, digital health, and more
To encourage robust, good-faith discussion about issues raised in First Opinion, STAT publishes selected Letters to the ...
某些結果已隱藏,因為您可能無法存取這些結果。
顯示無法存取的結果
意見反應